| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Options Exercise | $251,579 | +3,119 | +63% | $80.66 | 8,069 | 07 Mar 2025 | Direct | |
| transaction | XYL | Common Stock | Sale | $527,978 | -4,119 | -51% | $128.18 | 3,950 | 07 Mar 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Non-Qualified Stock Options (Right to Buy) | Options Exercise | $0 | -3,119 | -100% | $0.000000 | 0 | 07 Mar 2025 | Common Stock | 3,119 | $80.66 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,119 Shares were executed at a range of prices from $127.50 to $128.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| F2 | The February 27, 2020 option grant vested 1,030 options on February 27, 2021, 1,029 options on February 27, 2022, and 1,060 options on February 27, 2023. |